Found: 13
Select item for more details and to access through your institution.
Trends in Incidence and Clinical Outcomes of Clostridioides difficile Infection, Hong Kong.
- Published in:
- Emerging Infectious Diseases, 2021, v. 27, n. 12, p. 3036, doi. 10.3201/eid2712.203769
- By:
- Publication type:
- Article
Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21<sup>st</sup> century (GIVES-21).
- Published in:
- BMC Medical Research Methodology, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12874-023-01944-2
- By:
- Publication type:
- Article
Review article: bugs, inflammation and mood—a microbiota‐based approach to psychiatric symptoms in inflammatory bowel diseases.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2020, v. 52, n. 2, p. 247, doi. 10.1111/apt.15787
- By:
- Publication type:
- Article
Risk of alanine aminotransferase flare in patients with previous hepatitis B virus exposure on biological modifier therapies—A population‐based study.
- Published in:
- Liver International, 2023, v. 43, n. 3, p. 588, doi. 10.1111/liv.15499
- By:
- Publication type:
- Article
No increased risk of flare in ulcerative colitis patients in corticosteroid‐free remission after stopping 5‐aminosalicylic acid: A territory‐wide population‐based study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 7, p. 1284, doi. 10.1111/jgh.15838
- By:
- Publication type:
- Article
Gut microbiota‐derived synbiotic formula (SIM01) as a novel adjuvant therapy for COVID‐19: An open‐label pilot study.
- Published in:
- Journal of Gastroenterology & Hepatology, 2022, v. 37, n. 5, p. 823, doi. 10.1111/jgh.15796
- By:
- Publication type:
- Article
Use of thiopurines in inflammatory bowel disease: an update.
- Published in:
- Intestinal Research, 2022, v. 20, n. 1, p. 11, doi. 10.5217/ir.2020.00155
- By:
- Publication type:
- Article
Modulation of gut microbiota protects against viral respiratory tract infections: a systematic review of animal and clinical studies.
- Published in:
- European Journal of Nutrition, 2021, v. 60, n. 8, p. 4151, doi. 10.1007/s00394-021-02519-x
- By:
- Publication type:
- Article
The gut microbiome: an under-recognised contributor to the COVID-19 pandemic?
- Published in:
- Therapeutic Advances in Gastroenterology, 2020, v. 13, p. 1, doi. 10.1177/1756284820974914
- By:
- Publication type:
- Article
Discontinuation of Anti-Tumour Necrosis Factor Therapy in Patients with Perianal Fistulizing Crohn's Disease: Individual Participant Data Meta-Analysis of 309 Patients from 12 Studies.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 1, p. 134, doi. 10.1093/ecco-jcc/jjad118
- By:
- Publication type:
- Article
Childhood antibiotics as a risk factor for Crohn's disease: The ENIGMA International Cohort Study.
- Published in:
- JGH Open, 2022, v. 6, n. 6, p. 369, doi. 10.1002/jgh3.12755
- By:
- Publication type:
- Article
Effects of Gut Microbiome Modulation on Reducing Adverse Health Outcomes among Elderly and Diabetes Patients during the COVID-19 Pandemic: A Randomised, Double-Blind, Placebo-Controlled Trial (IMPACT Study).
- Published in:
- Nutrients, 2023, v. 15, n. 8, p. 1982, doi. 10.3390/nu15081982
- By:
- Publication type:
- Article
Processed Food as a Risk Factor for the Development and Perpetuation of Crohn's Disease—The ENIGMA Study.
- Published in:
- Nutrients, 2022, v. 14, n. 17, p. 3627, doi. 10.3390/nu14173627
- By:
- Publication type:
- Article